Combination therapies with anti-CD38 antibodies
US10604580B2 · kind B2 · utility
15Cited by
11References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2016 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | Dec 21, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.